@sargsyanz@hdx@NEJM Thank you, this is amazing! Updated version: gray shaded area represents the space of unstructured thinking, thanks @gradydoctor@HannahRAbrams@Anand_88_Patel for chiming in, your edits been so helpful in thinking about the nuanced ways we approach cases 🙏🏾
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Wanted to share something special: what brought me to twitter in the first place.
As a clerkship student, I was in awe of residents/attendings, and hoped to imitate not only their knowledge base but also their organized way of thinking.
My co-med student & friend Dr. Jarrod Ehrie and I started working on frameworks. We had support and mentorship from @NadiaBennettMD and Dr. Kogan. We spent years making the frameworks and having fellows then faculty review.
We asked medical students how they learn frameworks. Most said attending clinicians
An academic computing/web services core hosted the digital frameworks
📰 Why we do what we do in allogeneic transplantation for myeloid malignancies: Classic/Pivotal trials/papers.
Any you'd add/swap out?
1⃣ Chemo vs. Auto vs. Allo in AML
Cassileth PA et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. NEJM 1998
Gupta V et al. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010
2. @DrChrisHourigan and others have shown that AML pts with mutations at remission (molecular MRD) have more relapse➡️ inferior survival after HCT, especially if receiving reduced intensity conditioning. tinyurl.com/23rrbjte
3. We wondered:
1⃣ Is prognostic impact of MRD the same for patients age ≥ 60 (underrepresented in RCTs)?
2⃣ Is mutation persistence related to features present at diagnosis?
Two rising interns interested in🩸Heme-Onc & 📚MedEd
Teaching pearls from @NEJM CPC published 6/6/13
Dx spoilers below! @MedTweetorials
2/n First a PR:
Middle age man w/ PMHx HBV infection p/w chronic fevers and progressive weakness, found to have painful asymmetric mixed motor & sensory distal multiple mononeuropathy and nerve biopsy showing active vasculitis diagnosed with...
3/n DDx for mixed motor & sensory multiple mononeuropathy is broad!
▪️Hereditary
▪️Diabetes
▪️Vasculitis
▪️Infections (leprosy, lyme, syphilis, CMV, HIV)
▪️Neoplastic infiltration: (most commonly lymphomatous)
▪️Sarcoid, amyloid